Therapeutic Advances in Urology

该期刊采用CRediT（贡献者角色分类法，包含14种角色）描述每位作者的个人贡献，投稿时需列出各作者贡献，并在致谢部分之后加入“Author Contributions”标题。 模型中文摘要

As part of our commitment to ensuring an ethical, transparent and fair peer review and publication process, this journal has adopted CRediT (Contributor Roles Taxonomy). CRediT is a high-level taxonomy, including 14 roles, which is used to describe each author’s individual contributions to the work. You will be asked to list the contribution of each author as part of the submission process. Please…

在符合伦理和法律要求的前提下，期刊鼓励作者将研究数据存入相关公共数据仓库、提供链接数据的数据可用性声明（无法共享时说明原因）并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

涉及人类参与者、人类数据或人类组织的研究必须声明相关伦理委员会或机构审查委员会批准（或豁免批准），并提供委员会全称、所属机构及批准号；若无需伦理批准，须明确说明。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

Therapeutic Advances in Urology 为开放获取同行评审期刊，接受后立即免费在线发布并采用知识共享许可；投稿免费，但接受后需支付一次性文章处理费（标准APC为3200美元），由资助者、机构或作者承担。 模型中文摘要

Therapeutic Advances in Urology is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid …

该期刊实行单盲同行评审（审稿人姓名对作者保密），稿件先经初步评估，不符合要求可被退回修改或直接拒稿，通过后进入同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

期刊和Sage高度重视版权侵权、抄袭及其他违反出版最佳实践的问题，并可能据此采取相应措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

期刊接受已在预印本服务器发布的稿件，投稿时需在指定字段填写预印本DOI并告知编辑部，且同行评审期间不得在预印本服务器发布更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

根据ICMJE要求，临床试验须在招募首名参与者之前或当时在WHO认可的公共试验注册机构注册，作为考虑发表的条件，并在摘要末尾注明注册机构名称、URL及注册号。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.